Do you have Parkinson's Disease and Experience Hallucinations or Delusions?
What is the purpose of this study?
This study is being done to see if pimavanserin, a research medication, will help reduce hallucinations and/or delusions in patients with Parkinson's disease.
Can I participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions:Parkinson's Disease; Psychosis, hallucinations, visualisations, delusions, pimavanserin
Age: Between 40 - 100 Years
Gender: Male or Female
Detail Study Description
- You will take a research study medication, pimavanserin, or a placebo (lookalike pill containing no medicine).
- Neither you nor the research study staff will know if you are taking the research medication or the placebo.
- You will be asked to come to Cleveland Clinic 8 times over 26 weeks.
Placebo, Pimavanserin tartrate